Results 151 to 160 of about 188,070 (188)

Correlation between myeloproliferative diseases and T cell acute lymphoblastic leukemia: a case report and literature review. [PDF]

Hematol Transfus Cell Ther
Weihermann V, Maciel FVR, Velloso ED, Nardinelli L, Bendit I, Rocha V, Rego E, da Silva WF.   +7 more
europepmc   +1 more source

Aberrant immunophenotypic expressions in childhood acute leukemias: A tertiary care hospital experience. [PDF]

Pak J Med Sci
Saqlain N, Hareem S, Batool F, Mahmood K.   +3 more
europepmc   +1 more source

Mixed-phenotype acute leukemia, not otherwise specified, rare types B/T leukemia: a case report in the Jordanian Royal Medical Services. [PDF]

J Med Life
Ogeilat T, Al-Zghoul B, Maaita MJ, Al Zghoul A, Alkishk AA, Alqatamin H, Alnawaflh M, ALfarajat F, Masalha M, Qatawneh M, Al-Dabbas D, Shawabkah H, Al Qudah M, Mohammad A.   +13 more
europepmc   +1 more source

The Flow Cytometric Evaluation of B- and T-Lymphoblastic Leukemia/Lymphoma. [PDF]

Cancers (Basel)
Dorfman DM.
europepmc   +1 more source

Minor Myeloid Leukemic Populations in Pediatric Acute Lymphoblastic Leukemia: A Potentially Underrecognized Mixed-Phenotype Tumor? [PDF]

Int J Mol Sci
Semchenkova A, Lavrova P, Kozeev V, Demina I, Mikhailova E, Roumiantseva J, Lagoyko S, Kazakova A, Novichkova G, Karachunskiy A, Zerkalenkova E, Popov A.   +11 more
europepmc   +1 more source

Identification of an NFIA::CBFA2T3 fusion in cerebrospinal fluid confirms the diagnosis of pediatric CNS myeloid sarcoma with erythroid differentiation: a case report and literature review. [PDF]

Front Oncol
Zhao Y, Huang Z, Xue L, Zhang L, Jia Y.
europepmc   +1 more source

Applications of flow cytometry in equine medicine: current clinical and research perspectives. [PDF]

Front Vet Sci
Żak-Bochenek A, Lorek D, Partyka A, Siwińska N.   +3 more
europepmc   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm Expressing the CD13 Myeloid Antigen

Acta Haematologica, 2011
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), currently considered to originate from immature plasmacytoid dendritic cells (DC), is a rare and aggressive CD4+CD56+ neoplasm that frequently involves the skin and bone marrow. We present a case of an 80-year-old man with a CD4+CD56+ BPDCN that affected the orbital cavity and bone marrow.
Takayuki Ishikawa, Daichi Inoue, Seiji Nagano   +2 more
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

CD13 as a Potential Theranostic Target for Prostate-Specific Membrane Antigen-Negative Prostate Cancer and First-in-Human Study of [18F]AlF-CD13-L1 PET/CT Imaging

European Journal of Nuclear Medicine and Molecular Imaging
Approximately 10% of prostate cancer (PCa) are prostate-specific membrane antigen (PSMA)-negative, leading to blind spots in PSMA-based diagnosis. This study aimed to identify a potential target for PSMA-negative PCa and preliminarily evaluate the feasibility of using radionuclide probe targeting the identified target for PCa diagnosis.Quantitative ...
Wei Tang, Yi Cai, Shuo Hu
exaly   +3 more sources

Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67

British Journal of Haematology, 1993
Summary. A number of differentiation antigens on myeloid cells have been defined on the CD classification system by the four International Workshops on Human Leucocyte Differentiation Antigens. The distribution of eight of these antigens (CD13, CD14, CD16, CD31, CD36, CD65, CD66, CD67) have been studied in human tissues, with the aim of documenting ...
D, Bordessoule, M, Jones, K C, Gatter, D Y, Mason   +3 more
openaire   +2 more sources